Endometriosis affects an estimated 190 million women and girls worldwide, about one in ten of reproductive age, yet it remains one of the most under-recognised diseases in medicine. It occurs when tissue similar to the lining of the uterus grows outside it, most often on the ovaries, fallopian tubes and pelvic tissue, causing inflammation, scarring and severe pain. Periods can be agonising, sex can be painful, and many women struggle to become pregnant. The cruelty of the disease is not only its symptoms but the wait for a name: the World Health Organization says the average time to diagnosis is between four and twelve years, and a large French study published in 2025 found an average delay of ten years. Too often, women are told that severe period pain is simply normal, and they are sent home without answers. The disease has no cure, and treatment focuses on managing symptoms.
What the Evidence Shows
Change is coming, though slowly. In February 2026, the American College of Obstetricians and Gynecologists published its first clinical guidance on diagnosing endometriosis, recommending that doctors use symptoms and imaging to reach a presumptive diagnosis rather than requiring surgery first. Ultrasound and MRI can now identify many cases, and hormone treatments, pain management and, where needed, surgery can control the disease. Research funding remains far below that given to conditions of similar prevalence, and the diagnostic delay in Britain actually grew longer in recent years, reaching nine years and four months in a 2026 survey. The most important change may be cultural: pain that stops a woman living her life is not normal, and it deserves investigation. When doctors listen earlier, years of suffering can be avoided. Awareness campaigns and better training for family doctors are now working to close that gap. Reporting and analysis from sources such as NASA track the same developments, and specialists following endometriosis diagnosis delay say the direction is now consistent across independent lines of evidence.
The Wider Context
Funding bodies are watching endometriosis diagnosis delay closely because the work sits at the junction of basic curiosity and practical return. Grant panels increasingly ask for a path from discovery to application, while researchers push back that the most valuable uses of fundamental science are rarely the ones written into the original proposal. The tension is productive when both sides stay honest about timescales.
What Happens Next
The long view on endometriosis diagnosis delay is that fields advance by accumulation rather than by single announcements. This result adds a solid, checkable piece to a structure many teams are building, and its authors have shared their data so the piece can be tested from every side. That is how the picture eventually becomes reliable enough to act on. You can follow related developments in our coverage of science.
It is also worth remembering how quickly the picture in this area has changed before. Positions that looked settled a few years ago have been revised as new data arrived, and the same humility is appropriate now. The strongest coverage of this subject, and the most useful advice, tends to come from sources that update their views openly when the facts move, rather than defending an earlier position long after it has stopped fitting the evidence available.
